Experience of the Successful Treatment With Canakinumab of a Patient With Systemic Juvenile Idiopathic Arthritis

Experience of the Successful Treatment With Canakinumab of a Patient With Systemic Juvenile Idiopathic Arthritis

The article presents the follow-up of a patient with severe systemic juvenile idiopathic arthritis (JIA) resistant to glucocorticosteroids, to the first genetically engineered biologic drug (GEBD) tocilizumab, a monoclonal antibody to the interleukin (IL) 6 receptor. Switching to the second GEBD — a...

Full description

Bibliographic Details
Main Authors:	Ekaterina I. Alexeeva, Olga L. Lomakina, Tatiana M. Bzarova
Format:	Article
Language:	English
Published:	"Paediatrician" Publishers LLC 2017-06-01
Series:	Voprosy Sovremennoj Pediatrii
Subjects:	children systemic juvenile idiopathic arthritis canakinumab human monoclonal antibody to the interleukin 1β
Online Access:	https://vsp.spr-journal.ru/jour/article/view/1749

Similar Items

CLINICAL CASE OF CANAKINUMAB USE IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: R. V. Denisova, et al.
Published: (2013-09-01)

CLINICAL CASE: USE OF CANAKINUMAB IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS RESISTANT TO IMMUNOSUPPRESSANTS AND GENETICALLY ENGINEERED BIOPHARMACEUTICALS
by: E. I. Alexeeva, et al.
Published: (2014-03-01)

Myositis in the course of the systemic form juvenile idiopathic arthritis
by: Piotr Gietka, et al.
Published: (2014-06-01)

Administration of the Interleukin-1 Inhibitor Canakinumab in Children with Autoinflammatory Diseases and Systemic Juvenile Arthritis: the Report for Case Series
by: S. O. Salugina, et al.
Published: (2016-02-01)

Experiences with IL-1 blockade in systemic juvenile idiopathic arthritis – data from the German AID-registry
by: Elke Lainka, et al.
Published: (2021-03-01)

Experience of the successful treatment with canakinumab of a patient with NLPC4-associated autoinflammatory syndrome with enterocolitis
by: T. V. Sleptsova, et al.
Published: (2016-06-01)

IL-1 inhibition in systemic juvenile idiopathic arthritis
by: Gabriella Giancane, et al.
Published: (2016-12-01)

Therapy with canakinumab for gout
by: M. S. Eliseev, et al.
Published: (2019-04-01)

Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis
by: Jurgen Sota, et al.
Published: (2019-01-01)

Efficacy of Pneumococcal Polysaccharide Conjugate Vaccine (13-valent, Adsorbed) in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Genetically Engineered Biologic Drugs (Tocilizumab or Canakinumab): Prospective Cohort Study
by: Ekaterina I. Alexeeva, et al.
Published: (2020-08-01)

Review of International Registers of Patients with Systemic Juvenile Idiopathic Arthritis
by: Ekaterina I. Alekseeva, et al.
Published: (2017-04-01)

The role of IL-1 inhibition in systemic juvenile idiopathic arthritis: current status and future perspectives
by: Toplak N, et al.
Published: (2018-06-01)

Experience with etanercept, tocilizumab and interleukin-1 inhibitors in systemic onset juvenile idiopathic arthritis patients from the BIKER registry
by: Gerd Horneff, et al.
Published: (2017-11-01)

The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months
by: Timothy Beukelman, et al.
Published: (2017-04-01)

Correlations between serum interleukin 6, serum soluble interleukin 6 receptor, and disease activity in systemic juvenile idiopathic arthritis patients treated with or without tocilizumab
by: Soamarat Vilaiyuk, et al.
Published: (2019-07-01)

ADALIMUMAB IN TREATMENT OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: R. V. Denisova, et al.
Published: (2013-12-01)

Efficacy and Safety of Immunization With Pneumococcal Polysaccharide Vaccine in Children With Juvenile Idiopathic Arthritis: Preliminary Results of a Prospective Open-Label Study
by: Ekaterina I. Alexeeva, et al.
Published: (2017-06-01)

Treating Systemic Juvenile Idiopathic Arthritis with Tocilizumab: Clinical Case
by: E. I. Alekseeva, et al.
Published: (2016-11-01)

Fatal myocarditis in a child with systemic onset juvenile idiopathic arthritis during treatment with an interleukin 1 receptor antagonist
by: Zeft Andrew S, et al.
Published: (2012-04-01)

A case of acute lymphoblastic leukemia mimicking juvenile idiopathic arthritis
by: Ferhat Demir, et al.
Published: (2019-06-01)

Anti-cyclic citrullinated peptide antibodies in children with Juvenile Idiopathic Arthritis
by: Mohamed Hamooda, et al.
Published: (2016-09-01)

Comparison of different treatment modalities of tocilizumab in children with systemic juvenile idiopathic arthritis
by: M. M. Kostik, et al.
Published: (2013-09-01)

Immunology markers that can be predictive for the diagnosis of juvenile idiopathic arthritis
by: Sur Lucia M., et al.
Published: (2020-02-01)

The Use of Tocilizumab in 40 Patients With Polyarticular Juvenile Idiopathic Arthritis: the Results of a Retrospective Study
by: Mikhail M. Kostik, et al.
Published: (2017-06-01)

Kawasaki Disease and Systemic Juvenile Idiopathic Arthritis – Two Ends of the Same Spectrum
by: Ellen Go, et al.
Published: (2021-04-01)

Clinical experience with the interleukin-1β blocker canakinumab in patients with chronic tophaceous gout: abolishment of arthritis and prevention of exacerbations when allopurinol is used
by: M. S. Eliseev, et al.
Published: (2015-06-01)

Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches
by: Lina N. Zaripova, et al.
Published: (2021-08-01)

Elbow monoarthritis: an atypical onset of juvenile idiopathic arthritis Elbow monoarthritis: an atypical juvenile idiopathic arthritis onset
by: G. Simonini, et al.
Published: (2012-07-01)

EXPERIENCE OF USING METHOTREXATE IN A PATIENT WITH EARLY OLIGOARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
by: T. V. Sleptsova, et al.
Published: (2013-04-01)

Juvenile Idiopathic Arthritis and Oculopathy
by: А.К. Pavlyuchenko
Published: (2012-11-01)

Pneumococcal Vaccination of Patients with Juvenile Idiopathic Arthritis: Review of International Experience
by: Margarita A. Soloshenko, et al.
Published: (2017-04-01)

Canakinumab for refractory RA: a case report
by: Nikolaos Marketos, et al.
Published: (2018-01-01)

CLINICAL CASE OF USING TOCILIZUMAB FOR A FEMALE PATIENT WITH AN EARLY DEBUT OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: О. L. Lomakina, et al.
Published: (2014-10-01)

Clinical profile of juvenile idiopathic arthritis from a tertiary care hospital in Northern India
by: Arun Hegde, et al.
Published: (2020-01-01)

Vitamin D and juvenile idiopathic arthritis
by: Sarah L. Finch, et al.
Published: (2018-05-01)

EXPERIENCE OF APPLYING MONOCLONAL ANTIBODIES TO TNF α — ADALIMUMAB — IN A CHILD WITH JUVENILE IDIOPATHIC ARTHRITIS
by: E. I. Alexeeva, et al.
Published: (2013-07-01)

Juvenile Idiopathic Arthritis and Exercise
by: Pınar Kısacık, et al.
Published: (2016-04-01)

EXPERIENCE OF THE SUCCESSFUL CANAKINUMAB TREATMENT OF A PATIENT WITH UNDIFFERENTIATED AUTOINFLAMMATORY SYNDROME
by: Tatyana V. Sleptsova, et al.
Published: (2016-11-01)

EXPERIENCE OF ABATACEPT TREATMENT IN A PATIENT WITH ANTIBODY-POSITIVE IDIOPATHIC JUVENILE ARTHRITIS
by: T. M. Bzarova, et al.
Published: (2012-03-01)

EXPERIENCE OF METHOTREXATE USE IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: T. V. Sleptsova, et al.
Published: (2013-09-01)